DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
— - 1 Abbott - 1 Edwards - 1 Robert Ford - 1 necrotizing - 1 Ford - 1 they've - 1 Jim Cramer's - 1
Top related locs:
U.S Massachusetts Boston neonatologists Florida United New York New York City
Top related orgs:
Abbott Laboratories - 1 Revenue - 1 Abbott - 1 Libre - 1 Charitable Trust - 1 ABT - 1 Management - 1 NEC - 1

Search resuls for: "TBIs"


4 mentions found


☆ Abbott Labs' surprise guidance bump is a major positive for its shareholders
  + stars: | 2024-04-17 | by ( Zev Fima | ) www.cnbc.com   time to read: +7 min
Abbott Laboratories Why we own it : Abbott is a high-quality medtech company growing at a fast clip. As Abbott's organic sales growth continues to shine, the market will realize both concerns are overblown. We also love that EPS results on Tuesday came in above the range management had forecasted — a classic case of under-promising and over-delivering. ABT YTD mountain Abbott Laboratories YTD Organic growth was very strong, up nearly 11%, marking the fifth consecutive quarter of double-digit increases. In diagnostics, where we see the impact of the decline in Covid testing sales, organic sales increased 5.4% year over year.
Persons: —, Abbott, Edwards, Robert Ford, necrotizing, Ford, they've, Jim Cramer's, ABT, Jim Cramer, Jim Organizations: Abbott Laboratories, Revenue, Abbott, Libre, Charitable Trust, ABT, Management, NEC, Protality, TBIs, CNBC, Abbott Labs Locations: U.S
☆ How to fight dementia, according to neurologists
  + stars: | 2024-02-12 | by ( Sandee Lamotte | ) edition.cnn.com   time to read: +17 min
What about diabetes, cancer, thyroid disease, high blood pressure or heart disease? Some of the questions might seem unexpected to those who don’t write about brain health. However, my risk of developing vascular dementia, the second most common type after Alzheimer’s disease, is elevated. "Such spikes cause brain inflammation, disrupt brain metabolism and increase shrinkage of the thinking part of the brain," Isaacson said. The National Institute on Aging currently supports nearly 500 active clinical trials on Alzheimer’s disease and related dementias.
Persons: Louise Dittner, Krysta, Ryan LaMotte, It’s, ”, Natalia Rost, “, Rost, ” Rost, Richard Isaacson, ” Isaacson, mockingbird …, birthed, it’s, I’ve, Isaacson, Sandee LaMotte Organizations: CNN, Comprehensive, Massachusetts General Hospital, Harvard Medical School, American Academy of Neurology, Boca Raton, Weill Cornell Medicine, Presbyterian, Mayo Clinic, Volunteers, Alzheimer’s, National Institute on Aging, National Institutes of Health Locations: Massachusetts, Boston, neonatologists, Florida, United, New York, New York City, Nature
☆ A massive Iranian missile attack on a US base offered a glimpse of the long-lasting injuries US troops will face in a war with Russia or China
  + stars: | 2023-08-28 | by ( Paul Iddon | ) www.businessinsider.com   time to read: +6 min
In January 2020, Iran fired nearly a dozen ballistic missiles at an Iraqi base housing US troops. The hundreds of US troops at the base experienced what has been described as "the largest ballistic attack against Americans in history." The troops only received a few hours of warning, and the base had no air defenses capable of intercepting the missiles. US soldiers inspect damage from Iranian missiles at Al Asad air base on January 13, 2020. The Al Asad attack was a relatively small-scale demonstration of the lethal dangers that US troops will face on the battlefields of the future.
Persons: Qassem, Al Asad, Saddam Hussein, John Davison, Robert Hales, TBIs, Sarah Mattison, Kenneth McKenzie, McKenzie, Paul Iddon Organizations: Service, Reuters, US, American College of Surgeons, Iranian, Anadolu Agency, Getty, US Air National Guard / Tech, Marine Corps, Senate Armed Services Committee, US Central Command Locations: Iran, Wall, Silicon, Iranian, Iraq, Baghdad, Erbil, Al, Handout, Ukraine, Vermont
☆ U.S. FDA clears Abbott's blood test for concussions
  + stars: | 2023-03-07 | by ( ) www.reuters.com   time to read: +1 min
March 7 (Reuters) - The U.S. Food and Drug Administration has cleared Abbott Laboratories' (ABT.N) blood test that would help doctors assess traumatic brain injury (TBI), commonly known as concussions, the company said on Tuesday. The clearance marks the first commercially available laboratory blood test for TBI, according to the company, helping the doctors to rule out need for a CT scan in patients with mild TBI. Abbott already has a plasma test for TBI and was cleared by the FDA in 2021. The new test measures two indicators in the blood that, in elevated concentrations, are tightly correlated to brain injury, the company said. Reporting by Raghav Mahobe in Bengaluru; Editing by Shailesh KuberOur Standards: The Thomson Reuters Trust Principles.
0 next >>
Total: 4